The seventh batch of national drug collection work was launched in early July

Original title: The seventh batch of national drug collection is intended to open the bid in early July

A few days ago, the National Organic Pharmaceutical Cooperative Purchasing Office issued the "National Pharmaceutical Pharmaceutical Purchase Documents (GY-YD2022-1)" announcement, officially launched the seventh batch of national drug collection and mining work, and was planned to open the bid on July 12.

The documents stipulate the contents of the procurement variety and agreed procurement, procurement cycle and procurement agreement, application for qualification procurement execution instructions.

According to the documents, there are 61 national drug collection varieties, involving a variety of treatment areas such as malignant tumors, cardiovascular, diabetes, etc., including Afafitini oral interpretation, iodine glycol injections, and dual -dual -dual -pyramidine Release dosage form, etc.

In order to ensure the stable supply of drugs, this national drug collection exploration to explore the "preparation enterprise" method. According to the result of the selection of drugs, when the main supply enterprises cannot meet the market demand of the selected areas, the preparation enterprises can obtain the owner's identity in accordance with the relevant procedures to ensure the supply of drugs.

In terms of procurement execution, the documents are clearly clearing in the procurement cycle, medical institutions will give priority to the selection of products in this pharmaceutical collection and ensure that the agreed purchase volume is completed. On this basis, the remaining amount of medical institutions can purchase other drugs with appropriate prices in the same variety in accordance with the relevant regulations of the local drug collection management.

It is reported that the public application information disclosure will be carried out on the morning of July 12, using offline public or online live broadcasts. (Reporter Peng Yunjia)

- END -